Animas produces medical devices centered on the OneTouch Ping insulin pump and its associated firmware, a niche but critical product class where authentication and cryptographic reliability directly affect patient safety. The observed vulnerabilities cluster around improper authentication mechanisms and insufficient randomness in security-sensitive operations, both of which undermine the confidentiality and integrity of device communication. Current exploitation activity and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Animas over time
Signals from CVEs in this vendor scope (4 CVEs).
4 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2016-5686CRITICAL Johnson & Johnson Animas OneTouch Ping devices mishandle acknowledgements, which makes it easier for remote attackers to bypass authentication via a custom communication protocol. | Oct 5, 2016 | 9.8 | 32 | NO | NO |
CVE-2016-5086CRITICAL Johnson & Johnson Animas OneTouch Ping devices allow remote attackers to bypass authentication via replay attacks. | Oct 5, 2016 | 9.8 | 31 | NO | NO |
CVE-2016-5085HIGH Johnson & Johnson Animas OneTouch Ping devices do not properly generate random numbers, which makes it easier for remote attackers to spoof meters by sniffing the network and then | Oct 5, 2016 | 7.5 | 26 | NO | NO |
CVE-2016-5084HIGH Johnson & Johnson Animas OneTouch Ping devices do not use encryption for certain data, which might allow remote attackers to obtain sensitive information by sniffing the network. | Oct 5, 2016 | 7.5 | 25 | NO | NO |
Signals from CVEs in this vendor scope (4 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Animas.
Media articles that mention a CVE ID that affects a product developed by Animas — matched by CVE ID, not by vendor name.